Nephros (NEPH) Short Interest Ratio & Short Volume $1.54 +0.02 (+1.32%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Nephros Short Interest DataNephros (NEPH) has a short interest of 7,700 shares, representing 0.08% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 14,398 shares to cover all short positions.Current Short Interest7,700 sharesPrevious Short Interest7,700 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$11,935.00Short Interest Ratio0.7 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares10,540,000 sharesFloat Size9,240,000 sharesShort Percent of Float0.08%Today's Trading Volume8,797 sharesAverage Trading Volume14,398 sharesToday's Volume Vs. Average61% Short Selling Nephros? Sign up to receive the latest short interest report for Nephros and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNEPH Short Interest Over TimeNEPH Days to Cover Over TimeNEPH Percentage of Float Shorted Over Time Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Nephros Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20247,700 shares $11,935.00 No Change0.1%0.7 $1.55 11/15/20247,700 shares $12,012.00 -30.6%0.1%0.7 $1.56 10/31/202411,100 shares $16,095.00 +1,750.0%0.1%1 $1.45 10/15/2024600 shares $876.00 -76.9%0.0%0 $1.46 9/30/20242,600 shares $4,446.00 -25.7%0.0%0.2 $1.71 9/15/20243,500 shares $6,518.19 -23.9%0.0%0.3 $1.86 Get the Latest News and Ratings for NEPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter. 8/31/20244,600 shares $8,418.00 +119.1%0.1%0.4 $1.83 8/15/20242,100 shares $3,927.00 -30.0%0.0%0.2 $1.87 7/31/20243,000 shares $6,570.00 +76.5%0.0%0.2 $2.19 7/15/20241,700 shares $3,740.00 -55.3%0.0%0.1 $2.20 6/30/20243,800 shares $8,018.00 +52.0%0.0%0.3 $2.11 6/15/20242,500 shares $5,275.00 +316.7%0.0%0.2 $2.11 5/31/2024600 shares $1,308.00 -81.3%0.0%0 $2.18 5/15/20243,200 shares $6,560.00 +33.3%0.0%0.2 $2.05 4/30/20242,400 shares $5,448.00 +50.0%0.0%0.1 $2.27 4/15/20241,600 shares $3,184.00 -38.5%0.0%0.1 $1.99 3/31/20242,600 shares $5,694.00 +44.4%0.0%0.1 $2.19 3/15/20241,800 shares $3,906.00 -64.7%0.0%0.1 $2.17 2/29/20245,100 shares $16,116.00 +24.4%0.1%0.2 $3.16 2/15/20244,100 shares $14,391.00 -40.6%0.0%0.1 $3.51 1/31/20246,900 shares $24,495.00 -24.2%0.1%0.2 $3.55 1/15/20249,100 shares $31,213.00 -18.0%0.1%0.3 $3.43 12/31/202311,100 shares $38,406.00 -57.3%0.1%0.4 $3.46 12/15/202326,000 shares $74,880.00 -14.8%0.3%1.1 $2.88 11/30/202330,500 shares $69,845.00 +23.0%0.3%2.7 $2.29 11/15/202324,800 shares $51,336.00 +10.7%0.3%2.9 $2.07 10/31/202322,400 shares $36,957.76 -27.7%0.2%2.5 $1.65 10/15/202331,000 shares $50,840.00 +36.0%0.3%3.7 $1.64 9/30/202322,800 shares $33,744.00 -24.0%0.3%2.7 $1.48 9/15/202330,000 shares $42,600.00 -19.8%0.3%4.5 $1.42 8/31/202337,400 shares $61,336.00 -13.0%0.4%3.7 $1.64 8/15/202343,000 shares $64,930.00 +80.7%0.5%0.6 $1.51 7/31/202323,800 shares $32,844.00 -5.9%0.3%0.3 $1.38 7/15/202325,300 shares $35,420.00 -10.6%0.3%0.3 $1.40 6/30/202328,300 shares $43,865.00 -6.0%0.3%0.4 $1.55 6/15/202330,100 shares $44,849.00 +51.3%0.3%0.4 $1.49 5/31/202319,900 shares $31,840.00 +9.9%0.2%0.2 $1.60 5/15/202318,100 shares $22,697.40 -13.8%0.2%1.1 $1.25 4/30/202321,000 shares $29,820.00 -7.9%0.2%1.3 $1.42 4/15/202322,800 shares $32,376.00 -4.6%0.3%1.3 $1.42Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover 3/31/202323,900 shares $25,570.61 +17.7%0.3%1.3 $1.07 3/15/202320,300 shares $20,503.00 -18.8%0.2%1 $1.01 2/28/202325,000 shares $27,250.00 +12.6%0.3%1.1 $1.09 2/15/202322,200 shares $29,304.00 +30.6%N/A0.8 $1.32 1/31/202317,000 shares $22,948.30 -32.5%N/A0.6 $1.35 1/15/202325,200 shares $29,736.00 +50.9%N/A0.9 $1.18 12/30/202216,700 shares $19,325.24 -51.2%N/A0.6 $1.16 12/15/202234,200 shares $37,339.56 +12.1%N/A1.2 $1.09 11/30/202230,500 shares $31,720.00 +64.0%N/A1.1 $1.04 11/15/202218,600 shares $19,768.08 -14.3%N/A0.3 $1.06 10/31/202221,700 shares $22,785.00 -35.6%N/A0.4 $1.05 10/15/202233,700 shares $38,418.00 +15.4%N/A0.6 $1.14 9/30/202229,200 shares $26,572.00 +15.0%0.3%0.5 $0.91 9/15/202225,400 shares $30,734.00 -52.3%0.3%0.4 $1.21 8/31/202253,200 shares $75,012.00 +51.1%0.6%1 $1.41 8/15/202235,200 shares $60,192.00 +2.3%0.4%1.5 $1.71 7/31/202234,400 shares $51,256.00 +5.2%0.4%0.7 $1.49 7/15/202232,700 shares $50,031.00 -22.5%N/A0.6 $1.53 6/30/202242,200 shares $64,566.00 +32.7%N/A0.9 $1.53 6/15/202231,800 shares $51,834.00 -37.7%N/A0.7 $1.63 5/31/202251,000 shares $94,350.00 +82.1%0.6%0.8 $1.85 5/15/202228,000 shares $57,400.00 No Change0.3%0.4 $2.05 4/30/202228,000 shares $111,440.00 +7.7%0.3%0.7 $3.98 4/15/202226,000 shares $117,520.00 -3.0%0.3%0.8 $4.52 3/31/202226,800 shares $117,920.00 -15.2%0.3%0.8 $4.40 3/15/202231,600 shares $122,924.00 +26.4%0.4%0.9 $3.89 2/28/202225,000 shares $113,250.00 -13.2%0.3%1 $4.53 2/15/202228,800 shares $139,680.00 +20.0%0.3%1.5 $4.85 1/31/202224,000 shares $110,880.00 +3.9%0.3%1.5 $4.62 1/15/202223,100 shares $121,275.00 +9.0%0.3%1.7 $5.25 12/31/202121,200 shares $125,080.00 +12.8%0.2%1.8 $5.90 12/15/202118,800 shares $132,916.00 +5.0%0.2%2.3 $7.07 11/30/202117,900 shares $124,405.00 +16.2%0.2%2.5 $6.95 11/15/202115,400 shares $115,500.00 -3.8%0.2%2.3 $7.50 10/29/202116,000 shares $125,440.00 +8.8%0.2%2.3 $7.84 10/15/202114,700 shares $114,072.00 -9.8%0.2%2 $7.76 9/30/202116,300 shares $142,951.00 -10.9%0.2%2.4 $8.77 9/15/202118,300 shares $163,785.00 +24.5%0.2%2 $8.95 8/31/202114,700 shares $120,687.00 +17.6%0.2%1.7 $8.21 8/13/202112,500 shares $99,000.00 -28.2%0.1%1.4 $7.92 7/30/202117,400 shares $145,464.00 +0.6%0.2%1.9 $8.36 7/15/202117,300 shares $156,046.00 -44.7%0.2%1.7 $9.02 6/30/202131,300 shares $317,657.44 +82.0%0.4%3 $10.15 6/15/202117,200 shares $154,800.00 +22.9%0.2%1.5 $9.00 5/28/202114,000 shares $122,500.00 +15.7%0.2%1.1 $8.75 5/14/202112,100 shares $97,042.00 No ChangeN/A0.9 $8.02 4/30/202112,100 shares $95,469.00 +3.4%N/A0.8 $7.89 4/15/202111,700 shares $90,090.00 +9.4%N/A0.7 $7.70 3/31/202110,700 shares $73,509.00 +18.9%N/A0.6 $6.87 3/15/20219,000 shares $67,590.00 -9.1%N/A0.5 $7.512025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] 2/26/20219,900 shares $75,933.00 -20.8%N/A0.6 $7.67 2/12/202112,500 shares $106,875.00 +54.3%N/A0.6 $8.55 1/29/20218,100 shares $68,283.00 -8.0%N/A0.4 $8.43 1/15/20218,800 shares $70,400.00 -3.3%N/A0.6 $8.00 12/31/20209,100 shares $75,803.00 -18.0%N/A0.6 $8.33 12/15/202011,100 shares $82,029.00 +26.1%N/A0.7 $7.39 11/30/20208,800 shares $53,328.00 +23.9%N/A0.6 $6.06 11/15/20207,100 shares $44,446.00 -65.5%N/A0.5 $6.26 10/30/202020,600 shares $131,840.00 -7.6%N/A1.8 $6.40 10/15/202022,300 shares $148,072.00 +75.6%N/A1.9 $6.64 9/30/202012,700 shares $91,821.00 -26.2%N/A1 $7.23 9/15/202017,200 shares $121,260.00 +4.9%N/A1.4 $7.05 NEPH Short Interest - Frequently Asked Questions What is Nephros' current short interest? Short interest is the volume of Nephros shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 7,700 shares of NEPH short. 0.08% of Nephros' shares are currently sold short. Learn More on Nephros' current short interest. What is a good short interest ratio for Nephros? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NEPH shares currently have a short interest ratio of 1.0. Learn More on Nephros's short interest ratio. What is a good short interest percentage for Nephros? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.08% of Nephros' floating shares are currently sold short. What is Nephros' float size? Nephros currently has issued a total of 10,540,000 shares. Some of Nephros' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Nephros currently has a public float of 9,240,000 shares. How does Nephros' short interest compare to its competitors? 0.08% of Nephros' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Nephros: Outset Medical, Inc. (5.33%), Modular Medical, Inc. (1.16%), Cytosorbents Co. (2.51%), Nexalin Technology, Inc. (4.17%), Nutriband Inc. (0.79%), iCAD, Inc. (1.14%), Lucid Diagnostics Inc. (2.02%), Bellevue Life Sciences Acquisition Corp. (0.00%), CollPlant Biotechnologies Ltd. (0.09%), Spectral AI, Inc. (34.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Nephros stock? Short selling NEPH is an investing strategy that aims to generate trading profit from Nephros as its price is falling. NEPH shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nephros? A short squeeze for Nephros occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NEPH, which in turn drives the price of the stock up even further. How often is Nephros' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NEPH, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Outset Medical Short Squeeze Modular Medical Short Squeeze Cytosorbents Short Squeeze Nexalin Technology Short Squeeze Nutriband Short Squeeze iCAD Short Squeeze Lucid Diagnostics Short Squeeze Bellevue Life Sciences Acquisition Short Squeeze CollPlant Biotechnologies Short Squeeze Spectral AI Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NEPH) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nephros, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nephros With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEPH Stock Alerts